Sign Up to like & get
recommendations!
0
Published in 2020 at "Journal of Virology"
DOI: 10.1128/jvi.00321-20
Abstract: Rabies PEP depends on anti-RABV IgG, which is expensive and in limited supply in geographical areas with the highest disease burden. Replacing the IgG component with a cost-effective and shelf-stable small-molecule antiviral could address this…
read more here.
Keywords:
entry;
characterization;
small molecule;
anti rabv ... See more keywords